We fund research into many serious illnesses and conditions that impact the lives of children and their families.
Approximately 15,000 New Zealanders live with irritable bowel diseases including crohns and colitis, many of which develop in childhood and greatly affect the ability for children to live a normal life.
Approximately 150 children are diagnosed with a form of cancer every year. While medical advances have greatly improved the outcomes of many, there remain aggressive forms out there which are life-threatening, where even the best treatment options can impact adversely on a childs health.
We are increasingly understanding more about how children develop including greater insight into the plasticity of the brain in the early stages of life.
Disability is an umbrella term for many conditions that might impair a childs ability to perform an activity in a manner or range considered normal for a human being of that developmental stage.
One in 30 children are born with a congenital malformation, many life-threatening, requiring long-term health treatment.
New Zealand experiences a dramatically high number of sudden unexpected deaths in infancy (SUDI) when compared comparably wealthy countries, with vast ethnic disparities.
Infectious diseases are conditions caused by organisms such as bacteria, viruses, fungi or parasites. They can affect multiple organs of the body including the skin which is often subjected to infection by the bug Staphylococcus aureus, of which New Zealand has some of the highest rates in the developed world.
Issues relating to mental health are becoming increasingly salient with a rise in the incidence and prevalence of conditions such as depression, anxiety, autism spectrum disorder and ADHD. This proliferation over the past few decades is as varied as it is complex; including a greater awareness and increase in diagnoses, to the role played by environmental factors.
450 children develop epilepsy each year, dramatically reducing their quality of life and often resulting in death. Batten disease is a very rare inherited neurological disorder in children with no cure, nor effective treatments, and it invariably ends in premature death.
Obesity is becoming an increasingly critical health issue, especially so in children. Around 30 per cent of New Zealand children are overweight or obese, predisposing them to long-term, adverse health outcomes including coronary, heart disease, stroke, and diabetes among others.
Dental decay is the most chronic childhood disease, with more than 50 per cent of under-fives having decay which have numerous adverse effects on their short and long-term health.
Each year in New Zealand, approximately 500 babies are born very preterm, exposing them to a higher risk of a number of neuro developmental problems, including cerebral palsy and attention deficit hyperactivity disorder (ADHD). We also experience a dramatically high number of stillborn babies.
Acute respiratory illnesses are the leading cause of death in New Zealand children. The umbrella term of respiratory conditions includes bronchiectasis, pneumonia, asthma and cystic fibrosis.
RHD is a chronic, life-threatening condition initially caused by a strep throat infection and exacerbated by repeat bouts of rheumatic fever. New Zealand has some of the highest rates in the developed world.
Can provision of health, developmental and educational assessments help ensure all children in the Tamaki area are healthy, socially, emotionally and developmentally when starting school?
A randomised controlled trial to determine whether vitamin D supplementation in children for 12 months reduce the number of hospital readmission for ALRIs compared to the control group.
A trial into the effects of low ventilator flows compared with standard flows, to attempt to reduce lung injury in extremely preterm babies, thereby improving long-term health.
The use of robotic therapy to aid children with cerebral palsy to develop more effective gait patterns enabling them to walk faster, for longer periods of time, and with a more natural style.
A randomised control trial assessing the effectiveness of placing a stainless steel crown over decayed primary molar teeth in children to improve dental hygiene.
This project will refine current methods of gene therapy in a sheep model with the aim of expediting the therapy to clinical trials.
The search for, and assessment of, resilient antibiotics for effective treatment of skin infections through the screening of a unique collection of native New Zealand fungi.
Intrauterine growth restriction (IUGR) can result in severe health complications and currently has no treatment. This study will seek to improve the growth of these vulnerable infants.